Genedrive plc (AIM: GDR), a leading provider of point-of-care molecular diagnostics, has announced that the UK’s National Institute for Health and Care Excellence (NICE) is advising in a draft guideline
Genedrive plc (AIM: GDR), a leading provider of point-of-care molecular diagnostics, has announced that the UK’s National Institute for Health and Care Excellence (NICE) is advising in a draft guideline
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
Genedrive ® MT-RNR1 to commence roll out in Greater Manchester Project to follow NICE final recomendations scheduled for end of this month
Horizonte Minerals (HZM) announced that it has entered into a five-year mining services agreement, thereby securing services for mining, stockpile generation, plant feeding and slag handling activities for its 100%-owned
Antibiotic Induced Hearing Loss test receives preliminary recommendation by NICE NICE enters public consultation phase of Early Value Assessment of the Genedrive® MT-RNR1 System
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is  FTSE 100, Dax, Dow, Bitcoin, Alpha,
While its life on the stock market to date has been rather quiet, it could very well be the case that the latest news from URA Holdings (URAH), the Main
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dax 40, Dow, Bitcoin,
During the week Zak was fortunate enough to bump into a stockbroker who, with more than 30 years in the saddle, can be regarded as one of the leaders in
Genedrive file US FDA Pre-Submission for the Genedrive ® MT-RNR1 Product Range
Emmerson (EML), the Moroccan focused potash development company, announce it has reached agreement with Global Sustainable Minerals and Gold Quay Capital Pte Ltd to extend the commitment period for the